Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Study of the Effect of the Microbiome on Immune Checkpoint Inhibitor Response in Melanoma

NCT05102773 is registered in ClinicalTrials.gov with Ohio State University Comprehensive Cancer Center as lead sponsor.

NCT NCT05102773
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05102773 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Study of the Effect of the Microbiome on Immune Checkpoint Inhibitor Response in Melanoma
Lead sponsor
Ohio State University Comprehensive Cancer Center
Phase
Observational
Overall status
Completed
Start date
February 10, 2020
Completion date
May 5, 2022
Enrollment
88 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

clinical stage iv cutaneous melanoma ajcc v8, pathologic stage iv cutaneous melanoma ajcc v8